Literature DB >> 20719717

[Role of rosuvastatin in current lipid-lowering therapy].

Tatjána Abel1, János Fehér.   

Abstract

Statins are the most widely used lipid-lowering therapy. Among them, the rosuvastatin can be well tolerated and effectively helps to reach LDL-cholesterol goals in primary and secondary cardiovascular prevention. In addition, rosuvastatin reduces triglyceride and high-sensitivity C-reactive protein level and increases high-density lipoprotein (HDL) cholesterol, too. Imaging studies demonstrated that rosuvastatin therapy can not only reduce atherosclerosis progression but might induce its regression too.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20719717     DOI: 10.1556/OH.2010.28937

Source DB:  PubMed          Journal:  Orv Hetil        ISSN: 0030-6002            Impact factor:   0.540


  1 in total

1.  Rosuvastatin suppresses platelet-derived growth factor-BB-induced vascular smooth muscle cell proliferation and migration via the MAPK signaling pathway.

Authors:  Jianting Gan; Ping Li; Zhengdong Wang; Jian Chen; Xiangwen Liang; Ming Liu; Wenchao Xie; Ruixing Yin; Feng Huang
Journal:  Exp Ther Med       Date:  2013-08-20       Impact factor: 2.447

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.